Comparison between Aatmaj Healthcare IPO and Cell Point IPO.
IPO Details
Aatmaj Healthcare IPO is a SME Fixed Price IPO proposed to list at NSE SME while Cell Point IPO is a SME Fixed Price proposed to list at NSE SME.
Issue Size and Price
The total issue size of Aatmaj Healthcare IPO is up to ₹36.47 Cr whereas the issue size of the Cell Point IPO is up to ₹47.82 Cr. The final issue price of Aatmaj Healthcare IPO is ₹60.00 per share and of Cell Point IPO is ₹100.00 per share.
IPO Timetable
Aatmaj Healthcare IPO opens on Jun 19, 2023, while Cell Point IPO opens on Jun 15, 2023. The closing date of Aatmaj Healthcare IPO and Cell Point IPO is Jun 21, 2023, and Jun 20, 2023, respectively.
| | Aatmaj Healthcare IPO | Cell Point IPO |
|---|
| Issue Open | Jun 19, 2023 | Jun 15, 2023 |
| Issue Close | Jun 21, 2023 | Jun 20, 2023 |
| Basis Of Allotment (Tentative) | Jun 26, 2023 | Jun 23, 2023 |
| Initiation of Refunds (Tentative) | Jun 27, 2023 | Jun 26, 2023 |
| Credit of Share (Tentative) | Jun 29, 2023 | Jun 27, 2023 |
| Listing date (Tentative) | Jun 30, 2023 | Jun 28, 2023 |
Financials & KPIs
Aatmaj Healthcare IPO P/E ratio is 17.6, as compared to Cell Point IPO P/E ratio of 24.1.
Shares Offered
In the Aatmaj Healthcare IPO Retail Individual Investors (RII) are offered 30,39,500 shares while in Cell Point IPO retail investors are offered 30,39,500 shares. Qualified Institutional Buyers (QIB) are offered in Aatmaj Healthcare IPO and in Cell Point IPO.
| | Aatmaj Healthcare IPO | Cell Point IPO |
|---|
| Market Maker Reservation | 3,22,000 shares | 2,52,000 shares |
| NII | 30,39,500 shares | 23,91,000 shares |
| RII | 30,39,500 shares | 23,91,000 shares |
| Total | 60,79,000 shares | 47,82,000 shares |
Bids Received (Subscription)
Aatmaj Healthcare IPO subscribed 33.53x in total, whereas Cell Point IPO subscribed 6.01x.
